+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

A 20-person British firm that advises on huge deals made more than $105 million this year

Dec 20, 2016, 14:28 IST

LONDON - Robey Warshaw, a Mayfair-based M&A advisory firm with around 20 employees, made $105 million (£85 million) in fees in 2016, according to figures from Dealogic.

Advertisement

The firm, set up by former Morgan Stanley and UBS bankers Simon Robey and Simon Warshaw, advised on four mega-deals worth a total of $67 billion (£54.1 million) in 2016 against a backdrop of a cooling M&A market.

The boutique is growing fee revenue rapidly. It earned $37 million (£29.8 million) in the 18 months to March 31, 2015, according to accounts filed last year. The partners didn't draw a salary, but accounts show the "a profit of £9,414,881 is provisionally attributable" to the highest-earning member of the firm.

In 2016, Robey Warshaw advised Softbank on its £24 billion ($29.7 billion) takeover of chipmaker ARM as well as on the National Grid's sale of a stake in British Gas. The firm declined to comment on the Dealogic data.

Here's the Dealogic table for global M&A boutiques:

Advertisement

Dealogic

Meanwhile, total global deal volume dropped to $3.7 trillion (£2.9 trillion) from last year's record high of $4.7 trillion (£3.8 trillion). The dip follows three year-on-year rises.

Here's how that looks in context:

Dealogic

UK M&A plunged more than 50% in 2016, as political uncertainty and currency volatility hit dealmaking:
Dealogic

The value of withdrawn M&A topped $839 billion (£677.9 billion) globally in 2016, the highest since 2008.

"Two of the top five $100bn+ withdrawn deals on record, were pulled in 2016, led by Pfizer's $160bn bid for Allergan, withdrawn in April 2016 - the largest withdrawn deal on record," Dealogic said.

The fourth quarter of 2016 was more promising. The average deal size was $304 million (£245.6 million) - the highest quarterly average on record.

NOW WATCH: Martin Shkreli goes on a raging tweetstorm in response to high school students recreating his $750 drug for $2

Please enable Javascript to watch this video
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article